UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000003515 |
|---|---|
| Receipt number | R000004261 |
| Scientific Title | Phase II study of bevacizumab combined with oral leucovorin plus UFT for elderly patients with metastatic colorectal cancer. |
| Date of disclosure of the study information | 2010/04/26 |
| Last modified on | 2019/03/28 16:36:13 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2010/04/20 23:56:53 | ||
| 2 | Update | 2014/01/26 14:13:50 | Recruitment status Publication of results |
|
| 3 | Update | 2019/03/28 15:52:29 | Recruitment status Date of IRB Last follow-up date |
|
| 4 | Update | 2019/03/28 15:57:51 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Name of primary person or sponsor Organization Post marketing survey by drug manufacture etc., specified by Japanese law. Organization Organization Address Address Tel |
|
| 5 | Update | 2019/03/28 16:02:17 | Date of closure to data entry Date trial data considered complete Date analysis concluded |
|
| 6 | Update | 2019/03/28 16:35:11 | URL releasing protocol Publication of results URL related to results and publications Number of participants that the trial has enrolled Results Results Results date posted Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures |
|
| 7 | Update | 2019/03/28 16:36:13 | Other related information Other related information |
